Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

TheStreet's Action Alerts PLUS said Merck (MRK) - Get Report is benefiting from its Keytruda drug but Cramer prefers Eli Lilly (LLY) - Get Report , a holding of his charitable trust.

Watch all of Jim Cramer's latest videos, right here:

• Here Is Why Jim Cramer Doesn't Want to Buy More Starbucks Shares for Action Alerts PLUS
• Jim Cramer Reacts to Amazon's Big Quarterly Miss
• Jim Cramer Reacts to Chevron and Exxon Mobil Earnings
• Jim Cramer Reveals When to Buy Airline Stocks